This page is part of our 2021 average annual return archive: it shows the VRPX Average Annual return Since for calendar year 2021. This metric helps investors evaluate and compare performance among different stocks, over time.
Average annual return should be reviewed alongside overall market trends, and company fundamentals like earnings and revenue. As the saying goes on Wall St., past performance from 2021 does not guarantee future similar returns.
| VRPX Average Annual Return Chart Since 2021 | |||
Also see: • VRPX stock yearly return 2022 • VRPX stock yearly return 2023 • VRPX stock yearly return 2024 • VRPX stock yearly return 2025 • VRPX YTD return | |||
| Average Annual Return Benchmarks |
|
Compare VRPX average annual return versus benchmarks: S&P Average Annual Return Dow Average Annual Return Nasdaq 100 Average Annual Return Russell 2000 Average Annual Return Gold Average Annual Return 10 Year Treasury Average Annual Return |
| VRPX Share Performance |
| VRPX Average Annual Return Table Since 2021 | ||||||||||||||||||||||||||||||
VRPX average annual return is presented with the assumption of reinvestments of any dividends on ex-date. |
| About Virpax Pharmaceuticals Inc |
| Virpax Pharmaceuticals, Inc. is a preclinical-stage pharmaceutical company. Co. is focused on developing novel and proprietary drug delivery systems across various pain indication. Its drug-delivery systems and drug-releasing technologies being developed are focused on advancing non-opioid and non-addictive pain management treatments and treatments for central nervous system (CNS) disorders to enhance patients' quality of life. Its portfolio consists of multiple preclinical stage product candidates: Epoladerm, Probudur, Envelta, AnQlar and NobrXiol. Probudur is a single injection liposomal bupivacaine formulation being developed to manage post-operative pain. The VRPX average annual return since 2021 is shown above.
The Average Annual Return on the VRPX average annual return since 2021 page and across the coverage universe of our site, is a measure of the annualized return over the past ten years (or specified start date) for a given investment (up to the end of prior trading session recorded). Arguably, choosing ten years for a measurement period is on the one hand completely arbitrary, but on the other hand provides a sufficiently long window to capture long-term trends. Thus, researching Average Annual Returns is good practice for investors — whether VRPX average annual return since 2021 or other benchmarks/peers — and when doing so it is also important to factor in dividends, because a financial instrument's annualized return is more than just the change in price if that instrument pays a dividend or coupon. Our website aims to empower investors by performing the VRPX average annual return calculation with any dividends reinvested as applicable (on ex-dates). |
| VRPX Current Stock Quote |
 Free VRPX Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: Don't Forget Dividends in Average Annual Return! | |
|
| Average Annual Return Peers |
| VRPX (VRPX) is categorized under the Healthcare sector; to help you further research average annual return performance across stocks, below are some other companies in the same sector:
VRTX Average Annual Return |
Video: Don't Forget Dividends in Average Annual Return!